Clinical Neuroscience of HIV Infection Program

Overview

This program supports clinical neuroscience research on infants, children, adolescents, adults and the aging who are HIV infected or at risk for acquiring HIV. Specifically, the program encourages studies addressing neurocognitive, behavioral, and psychiatric consequences of living with HIV across the lifespan -- as well as factors that may modify the risk for, or the manifestation of, these consequences. In addition, the program encourages studies that utilize neuroscience and basic behavioral research-based approaches to optimize HIV prevention and treatment.

Areas of Emphasis

• Neurobehavioral consequences of HIV/AIDS and its treatments, its heterogeneity, and longitudinal course.
• Basic behavioral and neuroscience research (e.g., neuro-economics, neuro-marketing, decision science) addressing possible approaches for interventions to improve prevention and care.
• Neurobehavioral sequelae of perinatal and in-utero exposure to HIV, other infections, and related treatments.
• Neurobehavioral interventions to improve cognitive and behavioral function in HIV-associated neurocognitive disorders.

Basic neuroscience aspects of NeuroAIDS and its therapeutic approaches are covered by the HIV Neuropathogenesis, Genetics, and Therapeutics Branch.

Contact

Anaïs Stenson, Ph.D.   
5601 Fishers Lane,   
Rockville, MD 20852   
anais.stenson@nih.gov  
(240) 926-7572